Tuesday, August 16, 2022
wellness India Expo
Home Tags Study

Tag: Study

Revenue growth of hospitals to be moderate in FY2023: ICRA study

Aggregate occupancy for the sample set to be ~60-62% in FY2023; on a YoY basis, given the high base of FY2022, this translates to revenue growth of over 12%

US$ 10 billion oncology research to provide tailwinds to gene therapy...

Rising quest to search for breakthroughs in medical treatments have been fueling demand for gene therapy of various grades

Sputnik V demonstrates strong protection against Omicron variant, new study finds

This unique independent comparative study conducted by the Spallanzani Institute in Italy with results published in the vaccines peer-reviewed leading medical journal

First ever human patient dosed with Gene Therapy in Ocugen’s Phase...

This first patient dosing marks the beginning of the dose-escalating, observer-blind, Phase 1/2 safety and efficacy study

More Indian start-ups believe that the pandemic worked as an enabler...

As per the Medtronic-Economist Impact study, over three quarters of Indian healthcare start-ups (76.7%) believe that the pandemic was an enabler for innovation, unlike only 54.7% in the APAC region

AIIMS study: Warning labels on packaged food is people’s choice

The AIIMS study comes at a time when India is deliberating on an FOPL policy and public health experts across the world are keenly watching India’s choice of label design

First-ever study in India claims Covid-19 vaccine cocktails are safe

Mix and match of different vaccines is safe and elicits robust antibody response, revealed the study conducted by AIG Hospitals The first pilot study from India analyzing COVAXIN – COVISHEILD mixed doses

COVAXIN for children: Study demonstrates robust safety & immunogenicity in 2-18...

Whole-Virion inactivated SARS-CoV-2 Vaccine (BBV152) has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults......................

Global medicine spending to reach $1.8 trillion in 2026: IQVIA study

A total of 300 new drugs are expected to be launched over the next five years to 2026, significantly higher than levels seen on average during the past decade, and are expected to skew toward specialty, niche and orphan drugs

Women in white-collar jobs face biases due to health issues, Emcure...

‘The Indian Women’s Health Report 2021’ a study by Emcure Pharmaceuticals that surveyed working women of 25 to 55 years in white-collar jobs across 7 cities reveals prevalent societal stigma prevents most women from talking about their health-related issues........................